Original articleCardiovascularLong-Term Outcomes of Tricuspid Valve Replacement in the Current Era
Section snippets
Material and Methods
We retrospectively reviewed data on 81 consecutive patients who underwent TVR at the Brigham and Women’s Hospital over a 15-year period from January 1985 to December 1999. Data were extracted from the hospital’s computerized database with additional information obtained through retrospective chart review. We included all patients who underwent TVR either as an isolated procedure or in combination with other procedures. We included patients based on the completed surgical technique rather than
Operative and In-Hospital Mortality and Morbidity
The overall in-hospital mortality was 22% (n = 18). There was a tendency toward higher early mortality with bioprosthetic valves (n = 11, 32%) compared with mechanical valves (n = 7, 15%) (p = 0.06), but this difference did not persist beyond the first year. Twenty-four patients (29%) suffered from postoperative low cardiac output syndrome and 15 (18%) returned to the operating room for excessive postoperative bleeding. There were 2 patients (2%) who developed deep sternal wound infections and
Comment
In this series of patients undergoing tricuspid valve replacement in the current era, we have found that the procedure still has a very high immediate perioperative morbidity and mortality rate, and that there is a constant risk of death (up to 3% per year) in the medium-term to long-term outcome. In common with other published series [1, 2, 3, 4, 5], a majority of our patients had undergone previous cardiac surgery and were in New York Heart Association functional class III or IV. Although the
Requirements for Recertification/Maintenance of Certification in 2006
Diplomates of the American Board of Thoracic Surgery who plan to participate in the Recertification/Maintenance of Certification process in 2006 must hold an active medical license and must hold clinical privileges in thoracic surgery. In addition, a valid certificate is an absolute requirement for entrance into the recertification/maintenance of certification process. if your certificate has expired, the only pathway for renewal of a certificate is to take and pass the Part I (written) and the
References (15)
- et al.
Tricuspid valve replacementan analysis of 25 years of experience at a single center
Ann Thorac Surg
(2003) - et al.
Prosthetic replacement of the tricuspid valvebiological or mechanical?
Ann Thorac Surg
(1998) - et al.
Tricuspid valve replacementpostoperative and long-term results
J Thorac Cardiovasc Surg
(1995) - et al.
Prosthetic replacement of tricuspid valvebioprosthetic or mechanical
Ann Thorac Surg
(2002) - et al.
Biological or mechanical prostheses in tricuspid position? A meta-analysis of intra-institutional results
Ann Thorac Surg
(2004) - et al.
Tricuspid valve replacementUK Heart Valve Registry mid-term results comparing mechanical and biological prostheses
Ann Thorac Surg
(1998) - et al.
Tricuspid valve replacement with bioprostheseslong-term results and causes of valve dysfunction
Ann Thorac Surg
(2001)
Cited by (198)
Contemporary Outcomes of Isolated Tricuspid Valve Surgery
2023, Journal of Surgical ResearchConsiderations for Reoperative Heart Valve Surgery
2023, Structural Heart2021 ESC/EACTS Guideline on the diagnosis and treatment of valvular heart disease: Developed by the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Working Groups on the diagnosis and treatment of valvular heart disease
2022, Revista Espanola de CardiologiaTricuspid valve replacement: The old and the new
2022, Progress in Cardiovascular Diseases